Expanded carrier screening: What conditions should we screen for?
Open Access
- 18 January 2023
- journal article
- review article
- Published by Wiley in Prenatal Diagnosis
- Vol. 43 (4) , 496-505
Abstract
Carrier screening tests reproductive couples for their risk of having children affected by serious monogenic conditions. Carrier screening has historically been offered for certain conditions in high‐risk populations. However, more recent evidence has shown that offering carrier screening to all patients, regardless of their ethnicity, more effectively and equitably identifies at‐risk couples. Coupled with technology that enables screening for a nearly unlimited number of conditions, this expanded carrier screening (ECS) approach is now supported by professional society guidelines. Despite recent recommendations by the American College of Medical Genetics and Genomics to screen all patients who are pregnant or considering pregnancy for 113 conditions, questions remain about what conditions should be included on a core ECS panel. Here, we briefly review the history of carrier screening and guidelines on criteria for panel design. We then suggest which of these criteria are most critical, as well as thresholds to identify which conditions meet these criteria. Based on these interpretations, we recommend a core panel of 64 conditions that would identify the vast majority of at‐risk couples. Widespread adoption of a core panel such as this would result in a marked improvement in the number of patients currently receiving comprehensive carrier screening.Keywords
This publication has 38 references indexed in Scilit:
- Expanded Carrier Screening in Reproductive Medicine—Points to ConsiderObstetrics & Gynecology, 2015
- Systematic Classification of Disease Severity for Evaluation of Expanded Carrier Screening PanelsPLOS ONE, 2014
- ACMG clinical laboratory standards for next-generation sequencingGenetics in Medicine, 2013
- An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individualsGenetics in Medicine, 2013
- Committee Opinion No. 486: Update on Carrier Screening for Cystic FibrosisObstetrics & Gynecology, 2011
- A universal carrier test for the long tail of Mendelian diseaseReproductive BioMedicine Online, 2010
- Carrier screening for spinal muscular atrophyGenetics in Medicine, 2008
- Cystic fibrosis population carrier screening: 2004 revision of American College of Medical Genetics mutation panelGenetics in Medicine, 2004
- Genetic Testing for Cystic FibrosisArchives of internal medicine (1960), 1999
- Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network1993